Breaking Hamas Agrees to Disarm in U.S.-Brokered Deal; Regional Tensions Simmer Bureau of Reclamation Proposes Colorado River Water Use Cuts for Arizona, California, and Nevada Pollstar Ranks Top 20 Global Concert Tours Based on Box Office Performance Trump Signals Openness to Withdrawing Todd Blanche Nomination Amid Senate Concerns Minnesota Twins Acquire Left-Handed Reliever A.J. Minter in Trade with New York Mets

Friday July 31, 2026

Reporter

Medicus Pharma Ltd

3Articles Published

5Communities Covered

Published Articles

Press Release

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

6 hours ago

Press Release

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

Jul 27

Press Release

Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention

Jul 16